Home Biosimilar Antibodies Others Antibody-Drug Conjugate Datopotamab deruxtecan
For research use only. Not for use in humans.

Datopotamab deruxtecan

Synonyms: DS-1062, DS-1062A, Anti-TRP2/dxd

Datopotamab deruxtecan (DS-1062, DS-1062A, Anti-TRP2/dxd) is an antibody-drug conjugate (ADC) composed of a humanized anti-TROP2 monoclonal antibody, conjugated to topoisomerase I inhibitor, via a tetrapeptide-based linker. Datopotamab deruxtecan has the potential for use in solid tumors mainly in advanced unresectable advanced NSCLC.

Datopotamab deruxtecan

CAS No. 2238831-60-0

Click to purchase products related to Datopotamab deruxtecan

Quality Control

Batch: Purity: 99% Protein concentration: 14.37mg/ml Endotoxin Level: ＜1EU/mg
99

Specificity

Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description
Datopotamab deruxtecan (DS-1062, DS-1062A, Anti-TRP2/dxd) is an antibody-drug conjugate (ADC) composed of a humanized anti-TROP2 monoclonal antibody, conjugated to topoisomerase I inhibitor, via a tetrapeptide-based linker. Datopotamab deruxtecan has the potential for use in solid tumors mainly in advanced unresectable advanced NSCLC.
References

Product Details

CAS No. 2238831-60-0
DAR 4.2
ADC antiody Datopotamab
ADC linker A tetrapeptide-based linker
ADC cytotoxin Dxd
Formulation 100 mM Pro-Ac，20 mM Arg，pH 5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.